122 related articles for article (PubMed ID: 6396943)
1. [Anticoagulating properties of fungal proteases tricholysine (triase) and longolytin].
Serebriakova TN; Andreenko GV; Maksimova RA; Tsymanovich ST; Murashova NL
Vopr Med Khim; 1984; 30(5):37-40. PubMed ID: 6396943
[TBL] [Abstract][Full Text] [Related]
2. [Thrombolytic and pharmacodynamic properties of Aspergillus ochraceus protease].
Klöcking HP; Markwardt F
Farmakol Toksikol; 1975; 38(3):341-9. PubMed ID: 1084284
[TBL] [Abstract][Full Text] [Related]
3. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
[TBL] [Abstract][Full Text] [Related]
5. [Thrombolytic activity of terrilytin and its effect on the coagulating system of the blood].
Andreev SV; Kubatiev AA; Iurkov VA; Kol'tsova NL
Biull Eksp Biol Med; 1976 Aug; 82(8):936-7. PubMed ID: 1026291
[TBL] [Abstract][Full Text] [Related]
6. [Thrombolytic action of the enzymatic preparation terrilytin].
Grinberg GE; Mikhaĭlets GA
Probl Gematol Pereliv Krovi; 1972 Sep; 17(9):21-7. PubMed ID: 4668372
[No Abstract] [Full Text] [Related]
7. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
Cirillo R; Lippi A; Subissi A; Agnelli G; Criscuoli M
Thromb Haemost; 1996 Sep; 76(3):384-92. PubMed ID: 8883275
[TBL] [Abstract][Full Text] [Related]
8. [Effect of tricholysine on plasma fibrinolytic activity].
Serebriakova TN; Andreenko GV; Maksimova RA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (8):46-51. PubMed ID: 7196773
[No Abstract] [Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
[TBL] [Abstract][Full Text] [Related]
10. [Activation of the anticoagulation system following intravenous administration of beta-thrombin].
Strukova SM; Umarova BA; Semenova OA; Liapina LA; Kudriashov BA
Fiziol Zh SSSR Im I M Sechenova; 1979 May; 65(5):702-6. PubMed ID: 456683
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
12. The use of proteases as thrombolytic agents from the toxicological point of view.
Klöcking HP; Sedlarik K; Hentschel H
Pol J Pharmacol Pharm; 1980; 32(2):231-5. PubMed ID: 7005879
[TBL] [Abstract][Full Text] [Related]
13. [Development and production of a triase fibrinolytic preparation].
Gavrilov OK; Murashova NS; Kozlova MA; Sirotenko AV; Subbotina LA
Gematol Transfuziol; 1985 Aug; 30(8):51-6. PubMed ID: 3902558
[No Abstract] [Full Text] [Related]
14. [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
Pastorova VE; Liapina LA; Cherkasova KA; Ashmarin IP
Usp Fiziol Nauk; 1999; 30(2):80-91. PubMed ID: 10420478
[TBL] [Abstract][Full Text] [Related]
15. Isolated perfusion of pig liver. Effects of reptilase R in hemostasis (author's transl).
Chamone DF; Raia S; Mies S; Jamra M
Rev Bras Pesqui Med Biol; 1974; 7(4):427-33. PubMed ID: 4431989
[No Abstract] [Full Text] [Related]
16. [Fibrinolytic and thrombolytic effect of proteases from various fungal cultures].
Andreenko GW; Silaev AB; Maksimova RA; Poch LI; Serebrjakova TN
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):14-21. PubMed ID: 4134256
[No Abstract] [Full Text] [Related]
17. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
19. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution.
Caprini JA; Kwaan HC; Zuckerman L; Verduin R
Thromb Res; 1974 Feb; 4(2):199-217. PubMed ID: 4275415
[No Abstract] [Full Text] [Related]
20. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
